drugset / Trial / NCT00969449

Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan

NCT00969449

Phase 1 Completed 28 enrolled Bayer
RandomizedCrossoverOpen-labelTreatment

Summary

To compare the pharmacokinetic profile of the proposed extended- release tablet of naproxen sodium 660 mg relative to two tablets of Naprelan 500 mg following single dose administration for 36 hours under fasted conditions

Timeline

Start
2009-04
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule 500 mg
Subject Naproxen Small molecule 660 mg

Indications

No indication recorded.